Last --
Change Today 0.00 / 0.00%
Volume 0.0
4519 On Other Exchanges
Symbol
Exchange
4519 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Osamu Nagayama

Chairman and Chief Executive Officer, Chugai Pharmaceutical Co. Ltd.
AgeTotal Calculated CompensationThis person is connected to 38 board members in 5 different organizations across 5 different industries.

See Board Relationships
67¥356,000,000
As of Fiscal Year 2013

Background*

Mr. Osamu Nagayama has been the Chairman and Chief Executive Officer of Chugai Pharmaceutical Co. Ltd. since March 28, 2012. Mr. Nagayama served as President and Chief Operating Officer at Chugai Pharmaceutical Co. Ltd. until February 2012. He has been with Chugai Pharmaceutical Co. Ltd. since 1978. He served as a Director of Pharmaceutical Sales & Marketing Division and International Business Division of Chugai since 1983, Deputy General Manager of Pharmaceutical Research ...

Read Full Background

Corporate Headquarters*

1-1 Nihonbashi-Muromachi 2-Chome
Tokyo, -- 103-8324

Japan

Phone: 81 3 3281 6611
Fax: 81 3 3281 6607

Board Members Memberships*

Director and Chairman of the Board of Directors of Sony Corporation
1989-Present
Chairman and Chief Executive Officer
2005-N/A
Independent Director
2010-Present
Chairman of The Board and Chairman of Nominating Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary¥124,000,000
Bonus¥142,000,000
Total Annual Compensation¥266,000,000

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation¥266,000,000
Total Short Term Compensation¥266,000,000
Total Calculated Compensation¥356,000,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4519:JP ¥3,275.00 JPY -25.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€5.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.